← Evidence map

ArticlePloS one2024

Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation.

Katharina E Blankart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38696520